| Lot Release Number |
2020-08-20-0217
|
| FDA Registered Product/Generic Name |
Combined Diphtheria, Tetanus and Acellular Pertussis, Hepatitis B, Inactivated Poliomyelitis and Haemophilus influenzae Type B Vaccine (Preservative-free)
|
| Brand Name |
Infanrix Hexa
|
| Dosage Strength |
0.5 mL
|
| Dosage Form |
Suspension for Injection (I.M.)
|
| Registration Number |
BR-508
|
| Batch/Lot Number |
A21CD734 (DTPa-IPV-HepB: AC21B738A; HiB: AHIBD389C)
|
| Packaging Lot |
Packaging lot (box): A21CD734A
Pre-filled syringe: A21LD734A, MD: 02-2019, ED: 01-2022
Vial: A21FD734A, MD: 04-2019, ED: 03-2022
Needles (25G x 1"): 1910055, ED: 2024-09-30
|
| Product Expiration Date |
31 January 2022
|
| Issuance Date |
24 August 2020
|